November 18, 2024

SPT Labtech brings the power of miniaturization to more genomics researchers with mosquito® Gen3

SPT Labtech brings the power of miniaturization to more genomics researchers with mosquito® Gen3

This new instrument delivers automated true positive displacement technology in an exceptionally compact footprint

Cambridge, UK SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, has expanded its nanoliter liquid handling portfolio with the launch of mosquito Gen3. As the most compact and accessible model of the mosquito range, this new instrument brings next-generation sequencing (NGS) cost savings to more laboratories by lowering the barrier to advanced miniaturization technology.

mosquito Gen3 delivers accurate and precise multi-channel pipetting from 500 nL to 5 µL, with rapid plate-to-plate motion across three available deck positions and a small benchtop footprint[PL1] . Its use of individual pre-sterilized micropipettes eliminates the risk of cross-contamination, ensuring data and research integrity. Developed in collaboration with leading scientists, mosquito software enables quick method implementation and sharing, facilitating miniaturization in novel application areas.

For laboratories requiring higher throughput and greater walkaway capacity, mosquito HV genomics offers the same accuracy and volume range, with additional two deck positions.

mosquito technology has transformed genomics workflows by significantly reducing reagent consumption and scaling down reaction volumes without compromising data quality. Unlike traditional air displacement technology, mosquito’s true positive displacement technology maintains accuracy across all liquid classes and environmental conditions. This technology has enabled miniaturization of over 40 NGS kits, including industry standards such as Illumina Nextera XT, Illumina DNA Prep, NEBNext® Ultra™ II and Takara SMART-Seq chemistries. 

“Automated liquid handling has become essential for genomics labs to meet the demands of modern research. Miniaturization is a particularly advantageous technique that allows for substantial cost savings and maximum reach of precious samples and reagents. We’re lowering the cost barrier to miniaturization with mosquito Gen3, enabling more researchers to experience its benefits. Our expanded mosquito portfolio offers low-volume liquid handling solutions tailored to diverse laboratory resources and needs,” says Kamila Koprowska, Product Manager, mosquito genomics at SPT Labtech.

Contact

Carey Rooks, Head of Brand and Communications, SPT Labtech: marketing@sptlabtech.com

About SPT Labtech

SPT Labtech makes products that transform the way scientists work. For nearly two decades, our expert scientists, engineers, and business innovators have created innovative solutions for liquid handling, sample preparation and management that help accelerate research and make a real difference to human health. We work collaboratively with our customers, building trusted relationships that enable us to deliver exceptional, personalized experiences designed for real world challenges in the lab. For more information, please visit: www.sptlabtech.com

Follow SPT Labtech on Twitter @SPTLabtech and LinkedIn @SPT Labtech

Our latest News

discover more
Innovative medical products on their way to the clinic – GeneNovate successfully promotes entrepreneurial thinking in cutting-edge German research

Innovative medical products on their way to the clinic – GeneNovate successfully promotes entrepreneurial thinking in cutting-edge German research

After a pilot last year, GeneNovate, Germany’s first national entrepreneurship program for gene and cell therapies, took place for the second time. All participants in the program met in Berlin on 26 June for the joint closing event. There, they presented a total of 23 research projects to a high-caliber jury of business angels, venture […]

New Publication from Hummingbird Diagnostics GmbH: Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort

New Publication from Hummingbird Diagnostics GmbH: Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort

Alzheimer’s disease is the most common type of dementia, and early detection is important for better treatment. This study looked at small RNA molecules in the blood to see if they could help identify early signs of Alzheimer’s, especially in people with high levels of amyloid, a key Alzheimer’s marker. Researchers analyzed blood samples from […]

Medicine in the digital age: “MEDI:CUS” cloud for optimal healthcare

Medicine in the digital age: “MEDI:CUS” cloud for optimal healthcare

Data can save lives. However, in order for health data to be used for the benefit of patients, relevant data must be made available where it is needed. With the MEDI:CUS project, which is funded under the umbrella of the Forum Gesundheitsstandort Baden-Württemberg, the state of Baden-Württemberg is building a secure and data protection-compliant cloud-based […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp